If you choose medication therapy for post-traumatic stress disorder (PTSD), experts generally recommend selective serotonin ...
Astronaut Kellie Gerardi has been taking TikTok followers on her IVF journey. She announced in a heartbreaking video that her ...
Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.
A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...
In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that ...
A new study reveals that entacapone, a drug used to treat Parkinson’s disease, significantly disrupts the gut microbiome by ...
4d
Hosted on MSN15 New Drugs Selected for Medicare Price NegotiationsThe federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...
Rock Valley College (RVC) hosted a meeting for caretakers and friends to learn how to better care for people who suffer from Parkinson's Disease.
The past 50 years have seen remarkable advances in the science of medicine. The pharmacological treatments of disorders such as hypertension, immune disorders, and cancer are fundamentally different ...
Southern California drug developer in a deal that extends the combined companies' cash into 2027, months after it expects key ...
AstraZeneca’s diabetes drug Bydureon (exenatide) has failed to slow the progression of Parkinson’s disease motor symptoms in a Phase III trial. The University College London (UCL) in the UK ...
The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results